Quick Takeaways
- Franklin M. Berger has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,526,418.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Franklin M. Berger
- Location
- Brisbane, CA
- Summary
- The estimated net worth of Franklin M. Berger is at least $1,526,418 dollars as of 15 Oct 2025. Franklin M. Berger is the Director of Atea Pharmaceuticals, Inc. and owns shares of Atea Pharmaceuticals, Inc. (AVIR) stock worth about $1.53M.
- Signature
- /s/ Franklin Berger
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Franklin M. Berger and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Atea Pharmaceuticals, Inc. ($1,526,418).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Franklin M. Berger
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Director | $1,526,418 | 20 Jun 2025 | ||
| EPIX | ESSA Pharma Inc. | Director | $0 | 09 Oct 2025 | ||
| RAIN | Rain Oncology Inc. | Director | $0 | 26 Jan 2024 | ||
| BCEL | Atreca, Inc. | Director | 13 Jun 2023 | |||
| KZR | Kezar Life Sciences, Inc. | Director | 18 Jun 2025 |
Insider Transactions Reported by Franklin M. Berger:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.